MDL Consolidates More Than 100 Cases Against Makers of Birth Control Device Paragard District Judge Leigh Martin May has selected attorney Erin K. Copeland of Fibich, Leebron, Copeland & Briggs and Timothy Clark of Sanders Phillips Grossman to lead the Multidistrict Litigation (MDL) against the makers of Paragard intrauterine devices. The Paragard IUD was originally…
Firm Partner Erin Copeland Helps Lead Essure Lawsuit to Victory as a Lead Member of the JCCP Executive Committee On Thursday, Bayer announced it was settling the long-standing Essure® litigation for $1.6 billion. Attorney Erin Copeland has been a lead member of the court-appointed Plaintiffs’ Executive Committee for the Essure® JCCP pending in Oakland, California,…
Last week, a jury sitting for the U.S. District Court for the Northern District of California awarded the plaintiff a whopping $80 million in damages for injuries he suffered in connection with his prolonged exposure to the herbicide manufactured by the defendant, The Monsanto Company. The plaintiff, 70-year-old Edwin Hardeman, used Roundup for more than…
One day following the protest by Essure victims outside its corporate offices, Bayer, one of the leading pharmaceutical companies in the world, has announced that it will stop selling its Essure birth control device by the end of 2018. Essure has long been accused of triggering severe health complications in women, including but not limited to chronic…
Fibich, Leebron, Copeland & Briggs along with a team of other product liability firms recently obtained a remand of their Essure medical device cases back to a St. Louis, Missouri state court. Essure is a method of permanent birth control that has come under fire for the number of safety concerns raised by patients and cited in…
Erin K. Copeland of Fibich, Leebron, Copeland & Briggs will speak at the “Mass Tort Boot Camp” in Santa Barbara, CA, a seminar from the American Association for Justice (AAJ). At the seminar, Ms. Copeland will participate in three speaking events: Identifying a Viable Mass Tort: Case Selection (March 29, 9:00 – 9:45 a.m.), the Essure® Litigation Group Business…
Morcellators have been widely used by surgeons as a minimally invasive method of performing laparoscopic and myomectomy procedures. Women who suffer from painful uterine fibroids often undergo one of these procedures to remove them. Morcellators are designed to shred these fibroids, leaving only a small scar and requiring in a shorter recovery period than other…
The team at Fibich, Leebron, Copeland & Briggs is now actively reviewing cases from those who may have suffered adverse health effects through the use of popular weight loss drug Qsymia®. Qsymia is gaining an increasing amount of attention over its potential to cause serious side effects, including a particularly dreadful skin disease called Stevens-Johnson Syndrome….
Last month, Japanese auto part maker Takata announced that it would be expanding its recall of U.S. cars and trucks fitted with defective airbags. The expansion brought the recall to 34 million U.S. vehicles, making it the largest auto recall in American history. 53 million vehicles have been recalled worldwide. As part of the recall,…
Fibich, Leebron, Copeland & Briggs is proud to announce that two of our firm’s Partners – Tommy Fibich and Russ Briggs – were instrumental in the coordination of a $2.4 billion dollar settlement for Actos bladder cancer lawsuits. The settlement – which was reached on Tuesday April 28 th – is intended to compensate thousands of individuals who were allegedly diagnosed with bladder…
